Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets

NCT00853892 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Controlled-Release Oxycodone Hydrochloride 40 mg tablet
DRUG: OxyContin® 40 mg tablet

Sponsor

Mallinckrodt